Medtronic Acquires Lazarus Effect

Medtronic plc  (NYSE:MDT) today announced it has acquired Lazarus Effect, a Campbell, Calif.-based privately-held medical device company focused on acute ischemic stroke products that facilitate the capture and removal of clots.

BKW Health designed the Lazarus Effect website as well as created HCP videos.

See more at Cardiovascular News